Weighted Average Number of Shares Outstanding, Diluted of Sunshine Biopharma Inc. from 31 Dec 2021 to 30 Jun 2025

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Sunshine Biopharma Inc. quarterly and annual Weighted Average Number of Shares Outstanding, Diluted in shares history and change rate from 31 Dec 2021 to 30 Jun 2025.
  • Sunshine Biopharma Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 30 Jun 2025 was 3,604,653, a 8714% increase year-over-year.
  • Sunshine Biopharma Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 701,749, a 5372% increase from 2023.
  • Sunshine Biopharma Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 12,825, a 100% decline from 2022.
  • Sunshine Biopharma Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 15,180,868, a 481% increase from 2021.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)

Sunshine Biopharma Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2025 3,604,653 +3,563,757 +8714% 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 2,703,293 +2,061,983 +322% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 701,749 +688,924 +5372% 01 Oct 2024 31 Dec 2024 10-K 01 Apr 2025 2024 FY
Q3 2024 1,267,565 +1,254,720 +9768% 01 Jul 2024 30 Sep 2024 10-Q 05 Nov 2024 2024 Q3
Q2 2024 40,896 +28,221 +223% 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2025 2025 Q2
Q1 2024 641,310 +420,947 +191% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025 2025 Q1
Q4 2023 12,825 -15,168,043 -100% 01 Oct 2023 31 Dec 2023 10-K 01 Apr 2025 2024 FY
Q3 2023 12,845 -18,872,787 -100% 01 Jul 2023 30 Sep 2023 10-Q 05 Nov 2024 2024 Q3
Q2 2023 12,675 -15,836,843 -100% 01 Apr 2023 30 Jun 2023 10-Q/A 20 Aug 2024 2024 Q2
Q1 2023 220,363 -5,052,493 -96% 01 Jan 2023 31 Mar 2023 10-Q 20 May 2024 2024 Q1
Q4 2022 15,180,868 01 Oct 2022 31 Dec 2022 10-K 28 Mar 2024 2023 FY
Q3 2022 18,885,632 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023 2023 Q3
Q2 2022 15,849,518 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023 2023 Q2
Q1 2022 5,272,856 01 Jan 2022 31 Mar 2022 10-Q 10 May 2023 2023 Q1

Sunshine Biopharma Inc. Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 701,749 +688,924 +5372% 01 Jan 2024 31 Dec 2024 10-K 01 Apr 2025 2024 FY
2023 12,825 -15,168,043 -100% 01 Jan 2023 31 Dec 2023 10-K 01 Apr 2025 2024 FY
2022 15,180,868 +12,568,807 +481% 01 Jan 2022 31 Dec 2022 10-K 28 Mar 2024 2023 FY
2021 2,612,061 01 Jan 2021 31 Dec 2021 10-K 04 Apr 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.